Study of a cancer-related protein in colon cancer
Part of Cancer, Digestive system clinical trials.
This study looks at how a protein called butyrophilin is involved in colon cancer. It may help researchers understand colon cancer better and guide future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You can sign consent to join the study
- You have colon cancer that is either non-metastatic and can be removed, or metastatic to the liver where doctors planned a combined colon and liver operation
- You are generally able to care for yourself (performance status 0 or 1)
- You have colon cancer, not rectal cancer (and it’s not a recurrence)
- You have no serious issues that prevent study visits or exams
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects clinical and lab information from people who have surgery for colon cancer (or certain precancer growths) and related spread to organs. It may help researchers better understand colon cancer and improve future care, but it is not a new medication trial.
This study looks at a new drug that may help treat colorectal cancer, and also tests a blood marker that could help diagnose it. It is for people who are already scheduled to have their colorectal tumor removed with surgery.
This study looks at how gut bacteria and immune activity differ in normal, pre-cancer, and cancer colon tissue. It may help researchers understand what changes in the body are linked to colon growth and how they could be targeted in the future.
This study looks at how bacteria in your gut, your immune system, and colon cancer interact. It aims to understand these connections to improve future treatments.
This study is evaluating PreveCol, a new second-line stool test for people aged 50–69 who had a positive FIT/FOBT result and are already scheduled for a colonoscopy. It aims to find out if this test can help detect colorectal cancer earlier.
This study checks whether a blood test can help identify colorectal cancer or precancerous growths. You would have a planned colonoscopy, and researchers compare the blood test results to what the colonoscopy finds.
Hear when a new Colonic Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.